These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6879325)

  • 21. [Laser and chemotherapy and the immune status of patients with fibrous-cavernous tuberculosis].
    Sergeeva LV; Dobkin VG; Markov AN
    Probl Tuberk; 1996; (1):22-4. PubMed ID: 8907479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mumie as a pathogenetic agent in the treatment of tuberculosis].
    Agzamov RA; Arifkhanova SI; Vakhidova GA
    Probl Tuberk; 1988; (7):49-52. PubMed ID: 3265209
    [No Abstract]   [Full Text] [Related]  

  • 24. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of patients with contaminant HIV infection and tuberculosis].
    Shchelkanova AI; Kravchenko AV; Chukanov VI; Kasatkin GB
    Probl Tuberk; 2002; (12):39-42. PubMed ID: 12611335
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 27. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
    Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa
    Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis.
    Patel N; Deshpande MM; Shah M
    J Indian Med Assoc; 2002 Mar; 100(3):191-3. PubMed ID: 12408283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment effectiveness in newly detected patients with destructive pulmonary tuberculosis suffering from alcoholism].
    Molev VP; Golovko AF
    Probl Tuberk; 1986; (8):25-7. PubMed ID: 3774788
    [No Abstract]   [Full Text] [Related]  

  • 30. [Organization and effectiveness of tuberculosis treatment in alcohol abusers].
    Smirnov GA; Molofeev AN
    Probl Tuberk; 1979 Sep; (9):12-5. PubMed ID: 504126
    [No Abstract]   [Full Text] [Related]  

  • 31. [Artificial pneumothorax in the combined therapy of destructive pulmonary tuberculosis].
    Andrenko AA; Fedorova MV; Grishchenko NG; Tadzhieva NV
    Probl Tuberk; 1995; (1):43-5. PubMed ID: 7761382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumoperitoneum in the combined treatment of pulmonary tuberculosis in the elderly].
    Korneĭko GM
    Probl Tuberk; 1982 Nov; (11):48-50. PubMed ID: 7156105
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI; Gergert VIa; Khomenko IS
    Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses and immunostimulation in tuberculosis therapy.
    Gatner EM; Anderson R
    S Afr Med J; 1982 May; 61(19):707-10. PubMed ID: 6979105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of nerobol combined with tuberculin in the complex treatment of pulmonary tuberculosis].
    Tsishkevich FK; Gel'berg IS; Romaniuk SL; Alekso NI
    Probl Tuberk; 1976 Jan; (l):30-3. PubMed ID: 995903
    [No Abstract]   [Full Text] [Related]  

  • 36. [Complex treatment of destructive pulmonary tuberculosis].
    Shul'ga IA; Znosenko VA; Sukhorukova IS; Davydova GN; Surovtseva EIa; Shlapakova MA; Pelipas IG
    Probl Tuberk Bolezn Legk; 2003; (7):29-31. PubMed ID: 12939873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].
    Zhukova EM
    Probl Tuberk; 1995; (3):25-7. PubMed ID: 7617628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators].
    Khomenko IS; Chukanov VI; Gergert VIa; Utkin VV
    Probl Tuberk; 1990; (1):24-8. PubMed ID: 2336431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.